Sotac Pharmaceuticals Stock

Sotac Pharmaceuticals P/B

The P/B (Price-to-Book Ratio) of Sotac Pharmaceuticals (SOTAC.NS) as of Sep 4, 2026 is 2.59. In the previous year, P/B (Price-to-Book Ratio) was 3.05 — a change of -14.93% (lower).

P/B

2.59

YoY

-14.93%

Last updated:

P/B (Price-to-Book Ratio) of Sotac Pharmaceuticals is 2026 2.59 . P/B (Price-to-Book Ratio) of Sotac Pharmaceuticals was 2025 3.05 . It decreases by -14.93% lower compared to the previous year.

The Sotac Pharmaceuticals P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2020
45.18 INR
Jan 1, 2021
55.39 INR
Jan 1, 2022
20.86 INR
Jan 1, 2024
3.05 INR
Jan 1, 2025
2.59 INR
The Sotac Pharmaceuticals P/B history
YEARP/BYoY
2.59-14.93%
3.05-85.38%
20.86-62.34%
55.39+22.61%
45.18
Access this data via the Eulerpool API

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

P/B (Price-to-Book Ratio) of Sotac Pharmaceuticals is 2.59 in 2026.

P/B (Price-to-Book Ratio) of Sotac Pharmaceuticals changed from 3.05 to 2.59, representing a -14.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Sotac Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sotac Pharmaceuticals

All Key Metrics — Sotac Pharmaceuticals